News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-08-05-2015
Volume11
Issue 8

AMRI Acquires Gadea Pharmaceutical Group

AMRI expands its API portfolio and European presence through acquisition of Gadea’s Crystal Pharma Group.

AMRI announced July 16 that it has acquired the outstanding shares of Gadea Pharmaceutical Group, a privately held company located in Valladolid, Spain, specializing in technically complex APIs and finished drug product. The purchase price was $174 million, including the issuance of 2.2 million shares of common stock to Gadea's owners, valued at $43.8 million, with the balance paid in cash and through the assumption of existing debt.

Gadea, based in Valladolid, Spain, operates an API and finished-dose development and manufacturing business with 2014 revenue of approximately $83 million and 2014 adjusted EBITDA of approximately $17 million. The company has more than 400 customers selling into 70 countries with approximately 80% of revenue in non-US markets.

Gadea is expected to continue to operate independently within AMRI's API segment. Gerardo Gutierrez, Gadea's founder and chief executive officer, has joined the AMRI Board of Directors.

In a statement, AMRI outlined benefits of the transaction.  Gadea's Crystal Pharma division expands AMRI's marketable API portfolio and positions the company as a source of specialty and generic API.  Gadea's portfolio extends AMRI's API development and manufacturing capabilities in steroids and hormones. Acquisition adds ophthalmic and parenteral suspension dosage forms and prefilled syringe and lyophilization capability. In addition, the transaction establishes a European base for sales and operations and increases AMRI's presence into non-US markets.

Source: Albany Molecular Research Inc. (AMRI)

 

 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content